ArticleInfection and drug resistance2026
Antimicrobial Resistance in Intensive Care Units in Somalia: A Commentary on Measurement Gaps and Facility-Level Priorities for Infection Prevention and Stewardship.
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Microbial etiology and antimicrobial resistance patterns in neonates admitted to a tertiary neonatal intensive care unit in Mogadishu, Somalia.Frontiers in pediatrics · 2026Article
- Amphotericin B and Antifungal Stewardship in Somalia: Irrational Use, Misconceptions, and Emerging Challenges.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is increasingly shaping intensive care unit (ICU) care, where high antibiotic exposure, invasive devices, and prolonged hospitalization create favorable conditions for resistant pathogens to emerge and spread. Somalia is expanding emergency and critical care capacity, yet many facilities still face gaps in infection prevention and control (IPC), routine microbiology, unit-level antibiograms, and structured antimicrobial stewardship (AMS). This commentary integrates frontline ICU experience in Mogadishu, targeted non-systematic selection of Somali hospital studies, and operational guidance from the World Health Organization (WHO) and the US Centers for Disease Control and Prevention (CDC) to discuss pragmatic priorities for ICU AMR response. The aim is not to estimate national prevalence or demonstrate intervention effectiveness. Available studies from Mogadishu suggest substantial multidrug-resistant organism burdens in adult ICU, pediatric ICU, and hospital-acquired infections, while national IPC assessment findings and local stewardship evidence indicate important systems constraints. We argue that a realistic starting point is a minimum facility-level ICU AMR starter package consisting of six linked actions: defined accountability, audited IPC essentials, useful microbiology outputs including quarterly antibiograms, 48-72-hour antibiotic review, planned durations with stop dates, and protection of selected last-line agents using the WHO AWaRe framework. This package is presented as a pragmatic checklist for piloting and local adaptation rather than as a validated national framework. Strengthening measurement, IPC, and stewardship in sentinel hospitals may help generate the local data needed for future policy, quality improvement, and implementation research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.